Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02477358 · ClinicalTrials.gov registry record · NA
The Use of Platelet Rich Fibrin in Pulpal and Periodontal Regeneration in Mature Teeth
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02477358 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 18 participants.
The verdict
NCT02477358, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
In cases of permanent tooth avulsion, it is widely accepted that some necrosis always occurs after avulsion injury. If the pulp tissue does not revascularize or if endodontic therapy is not performed, the pulp space can become infected. Platelet rich fibrin (PRF) is a second generation platelet concentrate that allows the clinician to obtain fibrin membranes enriched with platelets and growth factors from an anticoagulant-free blood harvest. Clinical relevance of PRF and revascularization has been demonstrated in several case studies of avulsion. To date no human clinical trials have been performed evaluating the effectiveness of PRF on pulpal revascularization after reimplantation and its benefits in limiting inflammation. The following study consists of two phases: Phase 1: An in vitro model evaluating the effects of PRF in limiting inflammatory response of pdl cell cultures in the presence of an inflammatory mediators. Phase 2: An in vivo model utilizing mature teeth previously treatment planned for extraction, treating with PRF, reimplanting teeth and following for three to four months before extracting and performing histological analysis. If PRF is capable of promoting revascularization in mature teeth the potential benefits extend to limiting the need for endodontic therapy following mature tooth avulsion, potential for mature tooth transplantation in situations of congenitally missing teeth, and utilization of PRF in endodontic revascularization therapy.
Interventions
- PROCEDURE Left Tooth Platelet Rich Fibrin; Right Tooth Implant Alone
- PROCEDURE Right Tooth Platelet Rich Fibrin; Left Tooth Implant Alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-09-29 |
| Est. Completion | 2016-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02477358
The ClinicalTrials.gov registry entry for NCT02477358 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Left Tooth Platelet Rich Fibrin; Right Tooth Implant Alone is the first listed.
NCT02477358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02477358 about?
NCT02477358 is a clinical study titled "The Use of Platelet Rich Fibrin in Pulpal and Periodontal Regeneration in Mature Teeth". In cases of permanent tooth avulsion, it is widely accepted that some necrosis always occurs after avulsion injury. If the pulp tissue does not revascularize or if endodontic therapy is not performed, the pulp space can become infected. Platelet rich fibrin (PRF) is a second generation platelet conc...
What is the current status of trial NCT02477358?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2014-09-29. Estimated completion is 2016-06-01.
What interventions are being tested in trial NCT02477358?
The interventions under investigation include: Left Tooth Platelet Rich Fibrin; Right Tooth Implant Alone (PROCEDURE), Right Tooth Platelet Rich Fibrin; Left Tooth Implant Alone (PROCEDURE).
Who is sponsoring clinical trial NCT02477358?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.